C-reactive protein is a predictor for developing proteinuria in a screened cohort

Nephron - Clinical Practice

Volumn 117, Issue 1, 2010, Pages

  Iseki, Kunitoshi ^a,b   Iseki, Chiho ^a,b   Kinjo, Kozen ^a,b  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^b Okinawa General Health Maintenance Association   (Japan)

Author keywords

C reactive protein; Chronic kidney disease; Estimated glomerular filtration rate; Proteinuria

Indexed keywords

C REACTIVE PROTEIN; CREATININE;

ADULT; AGED; ARTICLE; AUTOANALYZER; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RISK ASSESSMENT; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 77955121851     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319647     Document Type: Article

References (26)

1. Iseki K, Tozawa M, Yoshi S, et al: Serum Creactive protein and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14: 1956-1960.
2. Zimmermann J, Herrlinger S, Pruy A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658.
3. Nakai S, Wada A, Kitaoka T, et al: An overview of regular dialysis treatment in Japan (as of 31 December 2004). Therap Apher Dial 2006; 10: 476-497.
4. Iseki K: Chronic kidney disease in Japan. Int Med 2008; 26: 13-17.
5. Konta T, Hao Z, Abiko H, et al: Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int 2006; 70: 751-756.
6. Nakamura M, Onoda T, Itai K, et al: Association between serum C-reactive protein levels and microalbuminuria: a populationbased cross-sectional study in northern Iwate, Japan. Int Med 2004; 43: 919-925.
7. Iseki K: Chronic kidney disease in Japan: from early predictions to current facts. Nephron Clin Pract 2008; 110: 268-272.
8. Iseki K: The Okinawa screening program. J Am Soc Nephrol 2003; 14(suppl 2):S127-S130.
9. Iseki K: Screening for renal disease: what can be learned from the Okinawa experience. Nephrol Dial Transplant 2006; 21: 839-843.
10. Matsuo S, Imai E, Horio M, et al: Revised equations for estimating glomerular filtration rate from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
11. Iseki K, Iseki C, Ikemiya Y, et al: Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-805.
12. Iseki K, Ikemiya Y, Iseki C, et al: Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63: 1468-1474.
13. Ruggenenti P, Perticucci E, Cravedi P, et al: Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008; 19: 1213-1224.
14. Fliser D, Wagner KK, Loos A, et al: Chronic angiotensin II receptor blockade reduces (intra) renal vascular resistance in patients with type 2 diabetes. J Am Soc Nephrol 2005; 4: 1135-1140.
15. Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
16. Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
17. Weiner DE, Tighiouart H, Elsayed EF, et al: Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int 2008; 73: 1406-1412.
18. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-394.
19. Imai E, Horio M, Yamagata K, et al: GFR decline rate in Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 2008; 31: 433-442.
20. Imai E, Horio M, Iseki K, et al: Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007; 11: 156-163.
21. Tozawa M, Iseki C, Tokashiki K, et al: Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007; 30: 937-943.
22. Ninomiya T, Kiyohara Y, Kubo M, et al: Metabolic syndrome and CKD in a general Japanese population: the Hisayama study. Am J Kidney Dis 2006; 48: 383-391.
23. Kambham N, Markowitz GS, Valeri AM, et al: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509.
24. Wang Y, Chen X, Song Y, et al: Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008; 73: 19-33.
25. Krikken JA, Lely AT, Bakker SJ, et al: The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 2007; 71: 260-265.
26. Yamagata K, Ishida K, Sairenchi T, et al: Risk factors for chronic kidney diseases in a community- based population: a 10-year followup study. Kidney Int 2007; 71: 159-166.